2016 annual financial data
Vanda Pharmaceuticals 2016 Revenue growth
Direct answer
Revenue growth was 32.83%.
Operating income was -18,571,000 USD and net income was -18,010,000 USD.
Operating cash flow was -8,103,000 USD.
Get free Vanda Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 146,017,000 USD
- Operating income
- -18,571,000 USD
- Net income
- -18,010,000 USD
- Operating cash flow
- -8,103,000 USD